Denmark· DK-28103921806
abseamed
A erythropoietin product containing epoetin alfa, registered in Denmark by MEDICE Arzneimittel Pütter GmbH & Co. KG. The same ATC class is registered in 12 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Erythropoietin is registered in 12 of 19 countries.
Countries holding a registration under ATC B03XA01 (erythropoietin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Erythropoietin · ATC B03XA01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- EPOETIN ALFA
- Manufacturer
- MEDICE Arzneimittel Pütter GmbH & Co. KG
- Country
- Denmark (DK)
- ATC code
- B03XA01
- ATC class
- Erythropoietin
- Defined daily dose
- 1 TSD, E
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28103921806
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
18 interactions on record for erythropoietin.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Erythropoietin · interactions on record
18 records
- 5 severe
- 3 moderate
- 10 minor
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- ThalidomideL04AX02severe
- LenalidomideL04AX04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B03XA01
Erythropoietin, as other registers publish it.
- FinlandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG
- FinlandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG
- FinlandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG
- FinlandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG
- FinlandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG
- FinlandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG
- FinlandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG
- IcelandAbseamedMedice Arzneimittel Pütter GmbH & Co. KG*
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/25515878-eeff-4cc5-beb8-bc609e10a5c5 GET /v1/drugs/25515878-eeff-4cc5-beb8-bc609e10a5c5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektionsvæske, opløsning i fyldt injektionssprøjte",
"source": "dkma",
"strength": "6000 IU/0,6 ml",
"auth_role": "MOD",
"dk_drugid": "28103921806",
"substance": "EPOETIN ALFA",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "41075"
}See everything about erythropoietin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.